- Home
- FLYW vs TVTX Comparison
FLYW vs TVTX Comparison
Compare FLYW & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLYW
- TVTX
- Stock Information
- Founded
- FLYW 2009
- TVTX 2008
- Country
- FLYW United States
- TVTX United States
- Employees
- FLYW N/A
- TVTX N/A
- Industry
- FLYW Computer Software: Prepackaged Software
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- FLYW Technology
- TVTX Health Care
- Exchange
- FLYW Nasdaq
- TVTX Nasdaq
- Market Cap
- FLYW 1.2B
- TVTX 1.4B
- IPO Year
- FLYW 2021
- TVTX N/A
- Fundamental
- Price
- FLYW $11.83
- TVTX $15.01
- Analyst Decision
- FLYW Buy
- TVTX Strong Buy
- Analyst Count
- FLYW 16
- TVTX 16
- Target Price
- FLYW $17.14
- TVTX $33.33
- AVG Volume (30 Days)
- FLYW 2.5M
- TVTX 1.5M
- Earning Date
- FLYW 08-05-2025
- TVTX 07-31-2025
- Dividend Yield
- FLYW N/A
- TVTX N/A
- EPS Growth
- FLYW N/A
- TVTX N/A
- EPS
- FLYW 0.04
- TVTX N/A
- Revenue
- FLYW $511,493,000.00
- TVTX $273,533,000.00
- Revenue This Year
- FLYW $17.98
- TVTX $73.84
- Revenue Next Year
- FLYW $15.56
- TVTX $46.72
- P/E Ratio
- FLYW $290.10
- TVTX N/A
- Revenue Growth
- FLYW 20.97
- TVTX 75.65
- 52 Week Low
- FLYW $8.20
- TVTX $7.72
- 52 Week High
- FLYW $23.40
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- FLYW 67.61
- TVTX 45.34
- Support Level
- FLYW $11.22
- TVTX $14.36
- Resistance Level
- FLYW $11.75
- TVTX $15.27
- Average True Range (ATR)
- FLYW 0.32
- TVTX 0.61
- MACD
- FLYW 0.08
- TVTX 0.15
- Stochastic Oscillator
- FLYW 87.79
- TVTX 71.13
About FLYW Flywire Corporation Voting
Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements namely a payments platform; a proprietary global payment network and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.